Literature DB >> 2467933

Carrier-induced epitopic suppression is initiated through clonal dominance.

M P Schutze1, E Deriaud, G Przewlocki, C LeClerc.   

Abstract

Injection of mice with an immunogenic dose of carrier followed by immunization with hapten-carrier conjugate selectively suppresses anti-hapten antibody response. Previous studies have proposed that this epitopic suppression is related to the induction of carrier-specific Ts cells which in turn could inhibit selectively anti-hapten response. In the present study, we propose that the epitopic suppression is in fact due to clonal dominance. Immunization with a carrier such as tetanus toxoid induces a clonal expansion of carrier-specific B cells, thus decreasing the probability of hapten-specific B cells to react with the Ag. Increasing the density of the TNP-hapten on the conjugate has totally prevented the induction of the epitopic suppression. Moreover, using low hapten-carrier concentrations to challenge carrier-primed mice has enhanced the induction of the suppression. Finally, priming hapten-specific B cells before carrier/hapten-carrier immunization has also abrogated the suppression. The results of these experiments support the view that epitopic suppression is induced through the expansion of the clones specific for the carrier epitopes and resulted from intra-molecular antigenic competition between hapten and carrier epitopes. Based on these findings a regulatory role is proposed for B cells, where through their capacity to process and present antigen, they would exercise a strong influence on the selection of immune responses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467933

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates.

Authors:  P J Brett; D E Woods
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine.

Authors:  T Barington; K Kristensen; J Henrichsen; C Heilmann
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

3.  Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation.

Authors:  J Zamorano; D Rivas; A Gayo; L Mozo; C Gutiérrez
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

4.  Carrier properties of a protein derived from outer membrane protein A of Klebsiella pneumoniae.

Authors:  I Rauly; L Goetsch; J F Haeuw; C Tardieux; T Baussant; J Y Bonnefoy; N Corvaia
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  B cells do not present antigen covalently linked to microspheres.

Authors:  A Galelli; B Charlot; E Dériaud; C Leclerc
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

Review 6.  Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.

Authors:  Michael E Pichichero
Journal:  Hum Vaccin Immunother       Date:  2013-08-16       Impact factor: 3.452

7.  Stable production of peptide antigens in transgenic tobacco chloroplasts by fusion to the p53 tetramerisation domain.

Authors:  Susana M Ortigosa; Alicia Fernández-San Millán; Jon Veramendi
Journal:  Transgenic Res       Date:  2009-12-02       Impact factor: 2.788

8.  Evaluation of two carrier protein-angiotensin I conjugate vaccines to assess their future potential to control high blood pressure (hypertension) in man.

Authors:  M R Downham; T R Auton; A Rosul; H L Sharp; L Sjöström; A Rushton; J P Richards; T G K Mant; S M Gardiner; T Bennett; J F Glover
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

9.  Bypass of carrier-induced epitope-specific suppression using a T-helper epitope.

Authors:  S Sad; K Rao; R Arora; G P Talwar; R Raghupathy
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

10.  Analysis of immunological nonresponsiveness to the 19-kilodalton fragment of merozoite surface Protein 1 of Plasmodium yoelii: rescue by chemical conjugation to diphtheria toxoid (DT) and enhancement of immunogenicity by prior DT vaccination.

Authors:  Danielle I Stanisic; Laura B Martin; Xue Q Liu; David Jackson; Juan Cooper; Michael F Good
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.